reviewThe Lancet OncologyJan 1, 2020BRONZE OA

Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation

University of Zurich · University Hospital of Zurich · +18 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

No related works found for this paper.

Funding